|
SOCS4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00189864685285E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.19949614077564E-11 |
| Normal-vs-Stage2 |
1.88830999999778E-05 |
| Normal-vs-Stage3 |
1.33889999975878E-07 |
| Normal-vs-Stage4 |
4.13799999998687E-06 |
| Stage1-vs-Stage2 |
7.511200E-01 |
| Stage1-vs-Stage3 |
4.998800E-01 |
| Stage1-vs-Stage4 |
5.839400E-01 |
| Stage2-vs-Stage3 |
8.126600E-01 |
| Stage2-vs-Stage4 |
7.760400E-01 |
| Stage3-vs-Stage4 |
9.155000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.71174227306892E-12 |
| Normal-vs-AfricanAmerican |
1.17210000039059E-07 |
| Normal-vs-Asian |
6.34629999999303E-05 |
| Caucasian-vs-AfricanAmerican |
3.927600E-01 |
| Caucasian-vs-Asian |
7.609200E-01 |
| AfricanAmerican-vs-Asian |
5.611000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.21853654838833E-12 |
| Normal-vs-Female |
1.27080000000834E-06 |
| Male-vs-Female |
1.315010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.1366999965814E-08 |
| Normal-vs-Extreme_Weight |
2.66020538930434E-12 |
| Normal-vs-Obese |
7.03489999587248E-09 |
| Normal-vs-Extreme_Obese |
1.260360E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.460800E-01 |
| Normal_Weight-vs-Obese |
5.011800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.136200E-01 |
| Extreme_Weight-vs-Obese |
2.194000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.228400E-01 |
| Obese-vs-Extreme_Obese |
8.633600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.89799999999308E-05 |
| Normal-vs-Age(41-60Yrs) |
2.44479999578218E-08 |
| Normal-vs-Age(61-80Yrs) |
9.4180219178952E-13 |
| Normal-vs-Age(81-100Yrs) |
2.45179998525913E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.020200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.146400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.534000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.514400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.905790E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.065450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67180047583315E-10 |
| Normal-VS-Type2 PRCC |
4.01845223763075E-12 |
| Normal-VS-KIRP CIMP |
1.165690E-02 |
| Normal-VS-Unclassified PRCC |
4.40390000000512E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.000100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.038600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.543000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.816600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.191600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.345200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.55031584528842E-15 |
| Normal-vs-N1 |
3.194100E-04 |
| Normal-vs-N2 |
1.13709999971512E-07 |
| N0-vs-N1 |
3.288200E-02 |
| N0-vs-N2 |
5.810300E-02 |
| N1-vs-N2 |
2.903500E-02 |
|
|
